In advanced periodontitis the total ulcerated pocket lining in contact with bacterial biofilm can approach the area of the palm of a hand. An open, chronically inflamed wound that size anywhere else on the body would not be treated as a local problem.
Gingivitis is inflammation of the gum tissue - bleeding, redness, swelling - and it is reversible. Periodontitis is what happens when the inflammatory response progresses to destroy the attachment apparatus: the periodontal ligament and the alveolar bone holding teeth in place. That destruction is not reversible.
The mechanism is not simple bacterial damage. Dysbiotic biofilm at the gum margin triggers a host inflammatory response, and it is largely that response - neutrophil-derived enzymes, matrix metalloproteinases, RANKL-driven osteoclast activity - that dissolves bone. The bacteria set the fire; the immune system does most of the burning.
Periodontitis raises circulating inflammatory markers including C-reactive protein and IL-6, and periodontal treatment lowers them. This is one of the better-replicated findings in the field, and it places gum disease among the identifiable contributors to the low-grade chronic inflammation that tracks with age-related disease.
Bacteraemia after chewing, brushing or flossing is well documented in people with periodontal disease - the ulcerated pocket lining is a direct portal into the circulation. Oral organisms and their products have been recovered from atherosclerotic plaque, and Fusobacterium nucleatum, an oral species, has attracted particular interest for its association with colorectal tumour tissue.
Both routes are plausible and both have supporting data. What remains unresolved in nearly every downstream association is whether they carry enough causal weight to matter clinically, or whether shared risk factors explain most of the correlation.
If you take one thing from this topic, take this one - it has the best evidence and a demonstrated treatment effect.
The relationship runs both ways. Hyperglycaemia impairs neutrophil function, promotes advanced glycation end-product accumulation in periodontal tissue, and worsens the inflammatory response, so poorly controlled diabetes drives more severe periodontal destruction. In the other direction, periodontal inflammation contributes to insulin resistance.
Crucially, this one has intervention data. Periodontal treatment in people with type 2 diabetes produces small but consistent HbA1c reductions across meta-analyses - typically a few tenths of a percentage point. That is not a diabetes cure, but for a dental cleaning it is a striking systemic effect, and it is the clearest demonstration that treating the mouth changes a measurement elsewhere in the body.
Observational studies consistently associate periodontitis with cardiovascular disease, and oral bacteria have been identified within atherosclerotic plaques. Mechanistically the story is coherent: chronic inflammation, repeated bacteraemia, endothelial dysfunction.
The problem is confounding, and it is severe. Smoking powerfully causes both conditions. So does diabetes. So do the socioeconomic factors determining access to both dental care and cardiology. Studies adjust for these, but residual confounding in this configuration is very hard to eliminate.
The honest position, reflected in statements from both dental and cardiology bodies: the association is real and consistent, periodontal treatment improves surrogate markers such as endothelial function and inflammatory markers, and no trial has yet shown that treating periodontitis reduces cardiovascular events. Treat gum disease because gum disease is worth treating - not as proven cardiac prevention.
This generated the most excitement and the most inflated coverage, and it is a useful case study in how a strong finding can still fail.
Work published in 2019 reported Porphyromonas gingivalis DNA and its gingipain proteases in the brains of people with Alzheimer's disease, with evidence that gingipains could damage tau and that inhibiting them reduced pathology in mice. It was a serious result in a serious journal, and it prompted a real clinical programme: a gingipain inhibitor tested in Alzheimer's patients.
That trial did not meet its primary endpoint. Subgroup signals were reported and debated, but the programme did not deliver what the hypothesis predicted. Independent groups have also questioned how specific the brain detection of oral bacteria really is, since low-level bacterial DNA turns up in many tissue samples.
Separately, large cohorts do report associations between periodontal disease or tooth loss and later dementia. But tooth loss is also a marker of decades of accumulated disadvantage, and early cognitive decline itself degrades oral hygiene - reverse causation is a live concern, not a technicality. The result: a biologically interesting hypothesis with a failed confirmatory trial. Not disproven, not established, and not a reason to sell anyone an oral-care product for brain health.
The interventions are cheap and almost aggressively boring, which is probably why they get less attention than the mechanisms.
Stop smoking. It is the largest modifiable risk factor for periodontal destruction, and it also suppresses gum bleeding - so it hides the main early warning sign while accelerating the disease.
Clean between the teeth daily. Brushing does not reach the interdental surfaces where periodontal disease preferentially begins. Where the space allows, interdental brushes outperform floss in most comparisons.
Match your recall interval to your risk. The fixed six-month check-up is convention rather than evidence; higher-risk patients need more, lower-risk patients may need less.
Treat bleeding gums as a finding, not a normal event. Healthy gums do not bleed with routine cleaning. “It always bleeds a bit” is a symptom being normalised.
Do not rely on mouthwash. Antiseptic rinses reduce plaque somewhat but do not substitute for mechanical disruption of the biofilm, and long-term chlorhexidine has its own trade-offs. There is also active research on antiseptic rinses disrupting oral nitrate-reducing bacteria that contribute to nitric oxide availability - interesting, unsettled, and not yet a reason to change routine either way.
No trial has demonstrated that. The association is consistent across observational studies and periodontal treatment improves surrogate markers, but smoking, diabetes and socioeconomic factors cause both conditions, and no study has shown reduced cardiac events from periodontal treatment.
No. The 2019 gingipain finding led to a real clinical trial of a gingipain inhibitor, and that trial did not meet its primary endpoint. Observational links between tooth loss and dementia exist but are confounded by lifetime disadvantage and by reverse causation, since cognitive decline itself worsens oral hygiene.
Yes, modestly, and this is the best-evidenced systemic effect. Meta-analyses in people with type 2 diabetes show small but consistent HbA1c reductions, typically a few tenths of a percentage point. The relationship is bidirectional, so improving either side tends to help the other.
The claim that flossing lacks evidence came from reviews noting that flossing trials are small, short and poorly designed - a statement about trial quality, not a demonstration that interdental cleaning is useless. Periodontal disease preferentially starts in the interdental spaces brushing cannot reach, so some form of daily interdental cleaning is well justified.
Not smoking. It is the largest modifiable risk factor for periodontal destruction and it suppresses gum bleeding, hiding the main early warning sign while accelerating the underlying disease.
Related buyer’s guide
Best Water Flossers 2026: Pressure, Tips and the Oral-Systemic Health Evidence
A 28-day fillable sleep log built around the seven levers that actually move sleep, so you test one per week and see what it did.
As an Amazon Associate, LongevityLab earns from qualifying purchases made through links on this page. This does not affect the price you pay.